This award supports innovative and high-impact research approaches to advance understanding and cure of bone marrow failure diseases. It is open to both early-career and established investigators. Applications do not require preliminary data but must demonstrate potential for interpretable results. Review criteria differ based on investigator status.
Open to established and early-career investigators from any eligible entity type. No restrictions on entity type are specified beyond general eligibility.
